Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jupiter Neurosciences (JUNS) EBIT Margin (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed EBIT Margin for 2 consecutive years, with 4496.72% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 1199277.0% to 4496.72% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 13493.97% through Dec 2025, up 1168211.0% year-over-year, with the annual reading at 40873.19% for FY2025, N/A changed from the prior year.
  • EBIT Margin for Q4 2025 was 4496.72% at Jupiter Neurosciences, down from 192544.26% in the prior quarter.
  • The five-year high for EBIT Margin was 199548.9% in Q2 2025, with the low at 7496.05% in Q4 2024.